Is Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street Analysts

Yahoo Finance09:18

The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts

BenzingaMar 21 04:00

Blueprint Medicines (BPMC): Among Stocks Insiders Are Selling In March

Yahoo FinanceMar 21 03:11

Morgan Stanley Initiates Blueprint Medicines(BPMC.US) With Hold Rating, Announces Target Price $100

Futu NewsMar 20 18:31 · Ratings

Express News | Blueprint Medicines Corp : Morgan Stanley Assumes Coverage With Equal Weight Rating; Price Target $100 Vs $120

BreakingsMar 20 18:22

Balanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics

TipRanksMar 20 17:05

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 15:00

Piper Sandler Initiates Blueprint Medicines(BPMC.US) With Hold Rating, Announces Target Price $119

Futu NewsMar 18 14:31 · Ratings

Wolfe Research Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $132

Futu NewsMar 18 14:31 · Ratings

Director's Major Stock Sale Shakes Up Blueprint Medicines!

TipRanksMar 18 10:06

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

BenzingaMar 18 01:22

Jefferies Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $135

Futu NewsMar 17 16:33 · Ratings

Scotiabank Initiates Coverage On Blueprint Medicines With Sector Outperform Rating, Announces Price Target of $150

BenzingaMar 8 06:41 · Ratings

Blueprint Medicines Insider Sold Shares Worth $1,434,209, According to a Recent SEC Filing

MT NewswiresMar 8 05:14

Leerink Partners Upgrades Blueprint Medicines(BPMC.US) to Hold Rating

Futu NewsMar 5 12:31 · Ratings

Blueprint Medicines: Hold Rating Amid Concerns Over Ayvakit's Liver Function Test Elevations

TipRanksMar 5 11:36 · Ratings

13 Analysts Assess Blueprint Medicines: What You Need To Know

BenzingaMar 4 06:00

Blueprint Medicines Price Target Maintained With a $125.00/Share by Citizens Capital Markets

Dow JonesMar 3 23:09 · Ratings

Blueprint Medicines Analyst Ratings

BenzingaMar 3 22:57 · Ratings

JMP Securities Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Cuts Target Price to $125

Futu NewsMar 3 14:31 · Ratings